Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CRN09682 |
| Synonyms | |
| Therapy Description |
CRN09682 comprises a non-peptide SSTR2 agonist with MMAE and a cleavable linker, which potentially inhibits growth of SSTR2-expressing tumors (Endocrine Abstracts (2024) 108 B23). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CRN09682 | CRN-09682|CRN 09682 | CRN09682 comprises a non-peptide SSTR2 agonist with MMAE and a cleavable linker, which potentially inhibits growth of SSTR2-expressing tumors (Endocrine Abstracts (2024) 108 B23). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07129252 | Phase Ib/II | CRN09682 | A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors (BRAVESST2) | Recruiting | USA | ESP | 0 |